Архитектура Аудит Военная наука Иностранные языки Медицина Металлургия Метрология Образование Политология Производство Психология Стандартизация Технологии |
Антисоциальное расстройство⇐ ПредыдущаяСтр 29 из 29
Фильмы и сериалы Психоз: «Сияние» (реж. Стэнли Кубрик, 1980) – Джек Торренс. Психопатия в сочетании с нарциссическим расстройством личности: «Исчезнувшая» (реж. Дэвид Финчер, 2014) – Эми. «Американский психопат» (реж. Мэри Хэррон, 2000) – Патрик Бейтман. «Старикам тут не место» (реж. братья Коэн, 2008) – Антон Чигур. «Уолл-стрит» (реж. Оливер Стоун, 1987) – Гордон Гекко. Сериал «Декстер» (Dexter, 2006) – Декстер Морган. Сериал «Фарго», 1-й сезон (Fargo, 2014) – Лорн Малво. Книги Хаэр Р. Лишенные совести. Пугающий мир психопатов. – М.: Вильямс, 2007. Даттон К. Мудрость психопатов. – СПб.: Питер, 2014. Томас М. Е. Исповедь социопата: Жить, не глядя в глаза. – М.: Азбука, 2015. Пограничное расстройство Фильмы «Тринадцать» (реж. Кэтрин Хардвик, 2003) – Трейси. «Антихрист» (реж. Ларс фон Триер, 2009) – жена. Книги Кейсен С. Прерванная жизнь. – СПб.: Амфора, 2006. Сноски 1 Подробнее о каждом из лекарств см. в соответствующих разделах. (обратно) 2 Адералл – лекарство от СДВГ, схожее с риталином. (обратно) 3 В этой главе мы решили не писать про аутизм в целом (хотя это, безусловно, интересная и заслуживающая внимания тема), а сконцентрироваться на высокофункциональном аутизме и синдроме Аспергера. С точки зрения стороннего наблюдателя, именно эти варианты расстройства ближе всего к «нормальности», их носители более или менее интегрированы в общество и визуально мало чем отличаются от обычных людей – и, соответственно, они с большой вероятностью могут встретиться среди ваших коллег, соседей и друзей. Притом от них ожидают того же, что и от обычных людей, поэтому неожиданные проявления их особенностей могут вызвать серьезное непонимание. (обратно) 4 Под таким названием перевод книги можно найти в Рунете. (обратно) 5 Использование должностным лицом своих служебных полномочий для удовлетворения личных амбиций вопреки интересам службы. Термин был впервые использован Ф. М. Достоевским в романе «Бесы». (обратно) 6 Не все герои упомянутых ниже художественных произведений имели официальные диагнозы, но их поведение, по мнению специалистов и/или больных психическими расстройствами, иллюстрирует особенности людей с тем или иным заболеванием. (обратно)(обратно) Комментарии 1 Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/ (обратно) 2 Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM – IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 Jun; 62(6): 617–27. (обратно) 3 Lenzenweger MF, Lane MC, Loranger AW, Kessler RC (2007). DSM – IV personality disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 62(6), 553–564. (обратно) 4 Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry. 1993 Feb; 50(2): 85–94. (обратно) 5 Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/ (обратно) 6 http://ria.ru/society/20141010/1027775155.html (обратно) 7 Kessler RC, Angermeyer M, Anthony Jc, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2007; 6(3): 168–176. (обратно) 8 http://gutta-honey.livejournal.com/113296.html (обратно) 9 Marazziti D, Akiskal HS, Rossi A, Cassano GB. Alteration of the platelet serotonin transporter in romantic love. Psychol Med. 1999 May; 29(3): 741–5. (обратно) 10 Bentall RP. A proposal to classify happiness as a psychiatric disorder. Journal of Medical Ethics. 1992; 18(2): 94–98. (обратно) 11 https://www.youtube.com/watch?v=G_Qwp2GdB1M (обратно) 12 Dima D, Roiser JP, Dietrich DE, Bonnemann C, Lanfermann H, Emrich HM, Dillo W. Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling. Neuroimage. 2009 Jul 15; 46(4): 1180–6. doi: 10.1016/j.neuroimage.2009.03.033.Epub 2009 Mar 24. (обратно) 13 Rosenhan DL. On being sane in insane places. Science. 1973 Jan 19; 179(4070): 250–8. (обратно) 14 Progler Y. Mental illness and social stigma: notes on "How Mad Are You?" Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2009; 14(5): 331–334. (обратно) 15 Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009. Se; 117(1–2): 1–17. (обратно) 16 Contribution of depression to cognitive impairment and dementia in older adults. Neurologist. 2007 May; 13(3): 105–17. (обратно) 17 American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing, p. 20. ISBN978–0–89042–555–8. (обратно) 18 Dalgleish T. The emotional brain. Nat Rev Neurosci. 2004 Jul; 5(7): 583–9. Review. (обратно) 19 Mega MS, Cummings JL, Salloway S, Malloy P. The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci. 1997 Summer; 9(3): 315–30. Review. (обратно) 20 Robert Sapolsky (2005). "Biology and Human Behavior: The Neurological Origins of Individuality, 2nd edition". The Teaching Company, p. 13 & 14 of Guide Book. (обратно) 21 Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb; 101(2): 131–81. Review. (обратно) 22 Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol. 2003 Jun; 63(6): 1223–9. (обратно) 23 Kennett GA, Ainsworth K, Trail B, Blackburn TP. BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology. 1997 Feb; 36(2): 233–9. (обратно) 24 Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation. 2000 Dec 5; 102(23): 2836–41. (обратно) 25 de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004 Apr; 26(2): 137–44. Review. (обратно) 26 Hofmann A. (1983). LSD, my problem child: Reflections on sacred drugs, mysticism, and science. Los Angeles: J. P. Tarcher. P. 21. (обратно) 27 Andersson A, Wiréhn A-B, Ölvander C, Ekman DS, Bendtsen P. Alcohol use among university students in Sweden measured by an electronic screening instrument. BMC Public Health. 2009;9:229. doi: 10.1186/1471-2458-9-229. (обратно) 28 Kellett J, Kokkinidis L. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications for kindling-associated fear and anxiety. Neuroscience. 2004; 127(2): 277–87. (обратно) 29 Ghaemi SN. The rise and fall of the biopsychosocial model. Br J Psychiatry. 2009 Jul; 195(1): 3–4. doi: 10.1192/bjp.bp.109.063859. (обратно) 30 Haygarth, John. (1800). Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the Literary and Philosophical Society of Bath. By John Haygarth, M.D. … Bath: printed by R. Cruttwell; and sold by Cadell and Davies, London. (обратно) 31 Beecher HK. The powerful placebo. J Am Med Assoc. 1955; 159(17): 1602–6. (обратно) 32 Howick J, Friedemann C, Tsakok M, et al. Are treatments more effective than placebos? A systematic review and meta-analysis. PLoS ONE. 2013; 8(5): e62599. (обратно) 33 Linde K, Fässler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond, B, Biol Sci. 2011; 366(1572): 1905–12. (обратно) 34 Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008; 65(2): 220–31. (обратно) 35 Oken BS. Placebo effects: clinical aspects and neurobiology. Brain. 2008; 131(Pt 11): 2812–23. (обратно) 36 Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci. 2006; 26(2): 559–63. (обратно) 37 Qiu YH, Wu XY, Xu H, Sackett D. Neuroimaging study of placebo analgesia in humans. Neurosci Bull. 2009; 25(5): 277–82. (обратно) 38 Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009; 1156: 198–210. (обратно) 39 Lidstone SC, Stoessl AJ. Understanding the placebo effect: contributions from neuroimaging. Mol Imaging Biol. 2007; 9(4): 176–85. (обратно) 40 Misra S. Randomized double blind placebo control studies, the "Gold Standard" in intervention based studies. Indian Journal of Sexually Transmitted Diseases. 2012; 33(2): 131–134. (обратно) 41 Levine R. A Real Mental Ward Becomes A Movie 'Cuckoo's Nest'. The New York Times. April 13, 1975. http://www.nytimes.com/packages/html/movies/bestpictures/cuckoo-ar1.html. Accessed Feb 25, 2016. (обратно) 42 Tooth GC, and Newton, MP: Leukotomy in England and Wales 1942–1954. London, Her Majesty's Stationary Office, 1961. (обратно) 43 Jansson B. Controversial Psychosurgery Resulted in a Nobel Prize. Nobel Media AB2014. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1949/moniz-article.html. Accessed Feb 25, 2016. (обратно) 44 Soares MS, Paiva WS, Guertzenstein EZ, et al. Psychosurgery for schizophrenia: history and perspectives. Neuropsychiatric Disease and Treatment. 2013; 9: 509–515. (обратно) 45 http://www.youtube.com/watch?v=yQa_sg4zN88 (обратно) 46 Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003; 361(9360): 799–808. (обратно) 47 Fitzgerald PB. Non-pharmacological biological treatment approaches to difficult-to-treat depression. Med J Aust. 2013; 199(6 Suppl): 48–51. (обратно) 48 Task Force on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Publishing, 2001. (обратно) 49 MacQueen G, Parkin C, Marriott M, Bégin H, Hasey G. The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder. Journal of Psychiatry & Neuroscience. 2007; 32(4): 241–249. (обратно) 50 Coentre R, Barrocas D, Chendo I, et al. [Electroconvulsive therapy: myths and evidences]. Acta Med Port. 2009; 22(3): 275–80. (обратно) 51 Cristancho MA, Alici Y, Augoustides JG, O'reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008; 10(6): 474–80. (обратно) 52 Wilkins KM, Ostroff R, Tampi RR. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol. 2008; 21(1): 3–11. (обратно) 53 Golenkov A, Ungvari GS, Gazdag G. Public attitudes towards electroconvulsive therapy in the Chuvash Republic. Int J Soc Psychiatry. 2012; 58(3): 289–94. (обратно) 54 Martin CD. Ernest Hemingway: a psychological autopsy of a suicide. Psychiatry. 2006; 69(4): 351–61. (обратно) 55 Swartz C. Electroconvulsive and Neuromodulation Therapies. Cambridge University Press; 2009. P. 185–187. (обратно) 56 Leopold T. (2016, November 18), Sam Phillips, Elvis and the invention of rock 'n' roll, CNN, Available at: http://edition.cnn.com/2015/11/18/entertainment/sam-phillips-sun-records-guralnick-feat/. Accessed February 24, 2016. (обратно) 57 Rawsthorn A. Yves Saint Laurent, a biography. Nan A. Talese; 1996. (обратно) 58 The Atlantic Monthly; January 1996; Bud's Bubble; Volume 277, No. 1; pages 99–102. (обратно) 59 Gardiner H. & Carey B., Researchers Fail to Reveal Full Drug Pay, The New York Times, Jun 8, 2008. (обратно) 60 Мартынихин И. О состоянии стационарных психиатрических учреждений РФ, Российское общество психиатров (6 декабря 2013 год, 09:35). http://psychiatr.ru/news/192 (обратно) 61 Reininghaus U, Priebe S, Bentall RP. Testing the Psychopathology of Psychosis: Evidence for a General Psychosis Dimension. Schizophrenia Bulletin. 2013; 39(4): 884–895. (обратно) 62 Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875): 1371–9. (обратно) 63 Maj M. «Psychiatric comorbidity»: an artefact of current diagnostic systems?. Br J Psychiatry. 2005;186: 182–4. (обратно) 64 Reininghaus U, Priebe S, Bentall RP. Testing the Psychopathology of Psychosis: Evidence for a General Psychosis Dimension. Schizophrenia Bulletin. 2013; 39(4): 884–895. (обратно) 65 Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005; 61(7): 835–54. (обратно) 66 World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. (обратно) 67 Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys. Epidemiologia e psichiatria sociale. 2009; 18(1): 23–33. (обратно) 68 Ciftci, Ayse, Nev Jones, and Patrick W. Corrigan. "Mental Health Stigma In The Muslim Community". Journal of Muslim Mental Health 7.1 (2013): n. pag. Web. (обратно) 69 Xu JM. Some issues in the diagnosis of depression in China. Can J Psychiatry. 1987; 32(5): 368–70. (обратно) 70 Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013; 10(11). (обратно) 71 Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013; 43(5): 897–910. (обратно) 72 Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys. Epidemiologia e psichiatria sociale. 2009; 18(1): 23–33. (обратно) 73 www.youtube.com/watch?v=NXB6slJSbL4 (обратно) 74 Saint Martin ML. Running Amok: A Modern Perspective on a Culture-Bound Syndrome. Primary Care Companion to The Journal of Clinical Psychiatry. 1999; 1(3): 66–70. (обратно) 75 http://theoryandpractice.ru/posts/11759-sosland (обратно) 76 Ablow K., We are raising a generation of deluded narcissists, Fox News, January 08, 2013. (обратно) 77 Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991–1992 and 2001–2002. Am J Psychiatry. 2006; 163(12): 2141–7. (обратно) 78 Andrade L, Caraveo-anduaga JJ, Berglund P, et al. The epidemiology of m. Int J Methods Psychiatr Rajor depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. 2003; 12(1): 3–21. (обратно) 79 Twenge JM, Gentile B, Dewall CN, Ma D, Lacefield K, Schurtz DR. Birth cohort increases in psychopathology among young Americans, 1938–2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010; 30(2): 145–54. (обратно) 80 Hollan DW, Wellenkamp JC. Contentment and suffering: Culture and experience in Toraja. Columbia Univ Pr; 1994. (обратно) 81 Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036. (обратно) 82 Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036. (обратно) 83 Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036. (обратно) 84 Hibbeln JR. Fish consumption and major depression. Lancet. 1998; 351(9110): 1213. (обратно) 85 Kitayama S, Markus HR, Matsumoto H, Norasakkunkit V. Individual and collective processes in the construction of the self: self-enhancement in the United States and self-criticism in Japan. J Pers Soc Psychol. 1997; 72(6): 1245–67. (обратно) 86 World Health Organization. Global health estimates 2014 summary tables: YLD estimates, 2000–2012, Available: http://www.who.int/entity/healthinfo/global_burden_disease/GHE_YLD_Global_2000_2012.xls. Accessed 20 September 2010. (обратно) 87 Merikangas KR, He J, Burstein M, et al. Lifetime Prevalence of Mental Disorders in US Adolescents: Results from the National Comorbidity Study-Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry. 2010; 49(10): 980–989. doi:10.1016/j.jaac.2010.05.017. (обратно) 88 Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U. S. Department of Health and Human Services; 2014. (обратно) 89 Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS data brief, no 94. Hyattsville, MD: National Center for Health Statistics. 2012. (обратно) 90 Prevalence of mood disorders in the rural population of Udmurtia. Pakriev, Acta Psychiatr Scand. 1998 Mar; 97(3): 169–74. (обратно) 91 Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med 1995; 4: 99–105. (обратно) 92 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994. (обратно) 93 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992. (обратно) 94 Tsuang MT, Taylor L, Faraone SV. An overview of the genetics of psychotic mood disorders. J Psychiatr Res. 2004; 38: 3–15. (обратно) 95 Nutt DJ (2008). "Relationship of neurotransmitters to the symptoms of major depressive disorder". Journal of Clinical Psychiatry. 69 Suppl E1: 4–7. (обратно) 96 Merzenich MM, Nelson RJ, Stryker MP, Cynader MS, Schoppmann A, Zook JM. Somatosensory cortical map changes following digit amputation in adult monkeys. J Comp Neurol. 1984; 224(4): 591–605. (обратно) 97 Davidson RJ, McEwen BS. Social influences on neuroplasticity: Stress and interventions to promote well-being. Nature neuroscience. 2012; 15(5): 689–695. doi: 10.1038/nn. 3093. (обратно) 98 Castrén E, Rantamäki T. Neurotrophins in depression and antidepressant effects. Novartis Found Symp. 2008; 289: 43–52. (обратно) 99 Castrén E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol. 2010; 70(5): 289–97. (обратно) 100 Goldman-Rakic PS (October 1996). The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 351(1346): 1445–53. (обратно) 101 X.T. Wang and Robert D. Dvorak. Sweet Future: Fluctuating Blood Glucose Levels Affect Future Discounting. Psychological Science, 21, 183–188. (обратно) 102 Maes M. "Functional" or "psychosomatic" symptoms, e. g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett. 2009; 30(5): 564–73. (обратно) 103 Ryan KA, Dawson EL, Kassel MT, et al. Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders. Brain. 2015; 138(Pt 5): 1424–34. (обратно) 104 Mackin P, Young AH, The Role of Cortisol and Depression: Exploring New Opportunities for Treatments, Psychiatric Times, 2004; 21: 92–5. (обратно) 105 Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med. 2013; 43(3): 449–69. (обратно) 106 Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(22): 12320–12322. (обратно) 107 Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. Hay PJ, ed. PLoS Medicine. 2013; 10(11): e1001547. (обратно) 108 Соломон Э. Демон полуденный: Анатомия депрессии. – М.: Добрая книга, 2004. (обратно) 109 Chronic Health Problems among U. S. Adults, by Poverty Status, 2011, Gallup Healthways Well-Being Index. (обратно) 110 Jonassen R, Chelnokova O, Harmer C, Leknes S, Landrø NI. A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women. Psychopharmacology (Berl). 2015; 232(5): 953–8. (обратно) 111 Selikoff IJ, Robitzek EH. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952; 21(4): 385–438. (обратно) 112 Burn JH. The Antihistamine Compounds. British Medical Journal. 1958; 2(5100): 845–846. (обратно) 113 Pletscher A. The discovery of antidepressants: a winding path. Experientia. 1991; 47(1): 4–8. (обратно) 114 Fagius J, Osterman PO, Sidén A, Wiholm BE. Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery, and Psychiatry. 1985; 48(1): 65–69. (обратно) 115 Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998; 59 Suppl 15: 42–8. (обратно) 116 Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006; 163(1): 41–7. (обратно) 117 Dunlop BW, Davis PG. Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review. Primary Care Companion to The Journal of Clinical Psychiatry. 2008; 10(3): 222–228. (обратно) 118 Постановление Правительства Российской Федерации от 4 февраля 2013 г. № 78 г. Москвы «О внесении изменений в некоторые акты Правительства Российской Федерации». (обратно) 119 Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry. 1999; 33(3): 323–7. (обратно) 120 Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, Severity, and Comorbidity of Twelve-month DSM – IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of general psychiatry. 2005; 62(6): 617–627. doi: 10.1001/archpsyc.62.6.617. (обратно) 121 Machado M, Einarson TR. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials. J Clin Pharm Ther. 2010; 35(2): 177–88. (обратно) 122 Nieuwstraten CE, Dolovich LR. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother. 2001; 35(12): 1608–13. (обратно) 123 Pagnin D, De queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004; 20(1): 13–20. (обратно) 124 Beltman MW, Voshaar RC, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010; 197(1): 11–9. (обратно) 125 Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008; 69(4): 621–32. (обратно) 126 U. S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health. (2015). Mental Health Information: Depression. Retrieved from http://www.nimh.nih.gov/health/topics/depression/index.shtml. (обратно) 127 Manber R, Kraemer HC, Arnow BA, et al. Faster Remission of Chronic Depression With Combined Psychotherapy and Medication Than With Each Therapy Alone. Journal of consulting and clinical psychology. 2008; 76(3): 459–467. doi: 10.1037/0022-006X.76.3.459. (обратно) 128 Lemmens LH, Arntz A, Peeters F, Hollon SD, Roefs A, Huibers MJ. Clinical effectiveness of cognitive therapy v. interpersonal psychotherapy for depression: results of a randomized controlled trial. Psychol Med. 2015; 45(10): 2095–110. (обратно) 129 Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression. 2. New York: Oxford University Press; 2007. (обратно) 130 Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003; 73(1–2): 123–31. (обратно) 131 Roccatagliata G. A History of Ancient Psychiatry. Praeger Pub Text; 1986. (pp. 230–231). (обратно) 132 Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47. (обратно) 133 Jamison KR. An Unquiet Mind, A Memoir of Moods and Madness. Vintage; 2009, p. 36. (обратно) 134 Jamison KR. Suicide and Bipolar Disorder. J Clin Psychiatry 2000; 61 (Suppl 9): 47–51. (обратно) 135 Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47. (обратно) 136 Kerner B. Genetics of bipolar disorder. The Application of Clinical Genetics. 2014; 7: 33–42. doi: 10.2147/TACG.S39297. (обратно) 137 Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875): 1371–9. (обратно) 138 Stein DJ, Kupfer DJ, Schatzberg AF. The American Psychiatric Publishing Textbook of Mood Disorders. American Psychiatric Pub; 2007: 159–75. (обратно) 139 Siegel D. Mindsight, Transform Your Brain with the New Science of Kindness. Oneworld Publications; 2010: 80–101. (обратно) 140 J. R. Whitwell, Historical Notes on Psychiatry. London: Lewis, 1936. (обратно) 141 Andreasen NC. The relationship between creativity and mood disorders. Dialogues in Clinical Neuroscience. 2008; 10(2): 251–255. (обратно) 142 Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989; 52(2): 125–34. (обратно) 143 Ludwig AM. Creative achievement and psychopathology: comparison among professions. Am J Psychother. 1992; 46(3): 330–56. (обратно) 144 Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA. Enhanced creativity in bipolar disorder patients: a controlled study. J Affect Disord. 2007; 100(1–3): 31–9. (обратно) 145 Kyaga S, Lichtenstein P, Boman M, Hultman C, Långström N, Landén M. Creativity and mental disorder: family study of 300,000 people with severe mental disorder. Br J Psychiatry. 2011;199(5): 373–9. (обратно) 146 Frederick K. Googwin, Kay Redfield Jamison. Manic-depressive ilness. Bipolar disorders and reccurent depression. Oxford University Press 2007. (обратно) 147 Figueroa c G. [Virginia Woolf as an example of a mental disorder and artistic creativity]. Rev Med Chil. 2005; 133(11): 1381–8. (обратно) 148 Ta-Wei Guu, Kuan-Pin Su. Musical creativity and mood bipolarity in Robert Schumann: A tribute on the 200th anniversary of the composer's birth. Psychiatry and Clinical Neurosciences 2011; 65: 112–114. (обратно) 149 Stephen G. Michaud, Hugh Aynesworth. The Only Living Witness: The True Story of Serial Sex Killer Ted Bundy. (обратно) 150 M. Fink, Delirious mania. Bipolar Disorders, vol. 1, no. 1, pp. 54–60, 1999. (обратно) 151 Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry. 2010;67(9): 931–8. (обратно) 152 https://www.psychologytoday.com/blog/inside-the-criminal-mind/201105/bipolar-illness-or-the-ups-and-downs-the-antisocial-persons (обратно) 153 Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord. 1999; 52(1–3): 135–44. (обратно) 154 Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. The American journal of psychiatry. 2013; 170(11): 1249–1262. doi: 10.1176/appi.ajp.2013.13020185. (обратно) 155 Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003; 160(12): 2099–107. (обратно) 156 Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014; 75(3): 254–62. (обратно) 157 Baethge C, Baldessarini RJ, Mathiske-schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2): 174–82. (обратно) 158 Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014; 2: 15. doi: 10.1186/s40345-014-0015-8. (обратно) 159 Van der loos ML, Kölling P, Knoppert-van der klein EA, Nolen WA. [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr. 2007; 49(2): 95–103. (обратно) 160 Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009; 61(2): 185–209. (обратно) 161 Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052. (обратно) 162 Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1): 4–9. (обратно) 163 Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi: 10.1186/s40345-014-0015-8. (обратно) 164 Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194 (1): 4–9. (обратно) 165 Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052. (обратно) 166 Ushkalova AV, Kostiukova EG, Mosolov SN. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(1 Vypusk 2 Depressiia): 23–30. (обратно) 167 Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder?. Can J Psychiatry. 2007;5 2(1): 14–21. (обратно) 168 Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 1999;108(4): 579–87. (обратно) 169 Miklowitz DJ. The Bipolar Disorder Survival Guide, Second Edition, What You and Your Family Need to Know. Guilford Press; 2011. (обратно) 170 Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012; 200(2–3):242–5. (обратно) 171 Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002; 4(3): 231–249. (обратно) 172 Ohman A, Lundqvist D, Esteves F. The face in the crowd revisited: a threat advantage with schematic stimuli. J Pers Soc Psychol. 2001; 80 (3): 381–96. (обратно) 173 Pittman CM, Karle EM. Rewire Your Anxious Brain, How to Use the Neuroscience of Fear to End Anxiety, Panic, and Worry. New Harbinger Publications Incorporated; 2014:16–24. (обратно) 174 Гоулман Д. Эмоциональный интеллект. – М.: ACT, 2009. (обратно) 175 Amunts K, Kedo O, Kindler M, et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol. 2005; 210(5–6): 343–52. (обратно) 176 Ledoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 2003; 23(4–5): 727–38. (обратно) 177 Tillich P, Gomes PJ. The Courage to be. New Haven [Conn.]: Yale University Press, 2000. (обратно) 178 World Health Organization. Global health estimates 2014 summary tables: YLD estimates, 2000–2012, Available: http://www.who.int/entity/healthinfo/global_burden_disease/GHE_YLD_Global_2000_2012.xls. Accessed 8 March 2010. (обратно) 179 Dupont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety. 1996; 2(4): 167–72. (обратно) 180 Lamers F, Van oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011; 72(3): 341–8. (обратно) 181 Kessler RC, Berglund PA, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM – IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry.2005 Jun; 62(6): 593–602. (обратно) 182 King, Helen (1993). "Once upon a text: Hysteria from Hippocrates". In Gilman, Sander; King; Porter, Helen; Rousseau, G.S.; Showalter, Elaine. Hysteria beyond Freud. University of California Press. (обратно) 183 May R. The Meaning of Anxiety. W. W. Norton; 2015: 40–67. (обратно) 184 Ibid. (обратно) 185 Kyaga S, Landén M, Boman M, Hultman CM, Långström N, Lichtenstein P. Mental illness, suicide and creativity: 40-year prospective total population study. J Psychiatr Res. 2013 47(1): 83–90. (обратно) 186 Silvia, P. J., & Kimbrel, N. A. (in press). A dimensional analysis of creativity and mental illness: Do anxiety and depression symptoms predict creative cognition, creative accomplishments, and creative self-concepts? Psychology of Aesthetics, Creativity, and the Arts. (обратно) 187 Dommermuth-Costa C. Nikola Tesla, A Spark of Genius. Twenty-First Century Books; 1994: 19–21. (обратно) 188 Jerry Bergman, Ph.D. 2004. Was Charles Darwin Psychotic? A Study of His Mental Health. Acts & Facts. 33 (1). (обратно) 189 Panter B, Virshup B. Psychological Studies of Art and Artists. 1996. (обратно) 190 Фрейд З. Введение в психоанализ. Лекции. – СПб.: Азбука, 2014.. (обратно) 191 Izard CE. The Psychology of Emotions. Springer; 2004. 308–12. (обратно) 192 Klein DF. Historical aspects of anxiety. Dialogues in Clinical Neuroscience. 2002; 4(3): 295–304. (обратно) 193 Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005; 81(2): 341–54. (обратно) 194 Grinde B. An approach to the prevention of anxiety-related disorders based on evolutionary medicine. Prev Med. 2005; 40(6): 904–9. (обратно) 195 Price JS. Evolutionary aspects of anxiety disorders. Dialogues in Clinical Neuroscience. 2003; 5(3): 223–236. (обратно) 196 Watson JB, Rayner R. Conditioned emotional reactions. 1920. Am Psychol. 2000; 55(3): 313–7. (обратно) 197 Beck, H. P., Levinson, S., & Irons, G. (2009). "Finding Little Albert: A journey to John B. Watson's infant laboratory". American Psychologist, 64, 7. (обратно) 198 Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009; 66(12): 1361–72. (обратно) 199 Adolphs R, Tranel D, Hamann S, et al. Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia. 1999; 37(10): 1111–7. (обратно) 200 Haygarth, John. (1800). Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the Literary and Philosophical Society of Bath. By John Haygarth, M.D. … Bath: printed by R. Cruttwell; and sold by Cadell and Davies, London. (обратно) 201 Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry. 2003; 64 Suppl 3: 21–7. (обратно) 202 Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, et al. Practice guideline for the treatment of patients with panic disorder. Arlington, VA: American Psychiatric Association, 2009. (обратно) 203 Association, American Psychiatric (2013). Diagnostic and statistical manual of mental disorders: DSM-5. (5th ed.). Washington, D.C.: American Psychiatric Association. p. 222. (обратно) 204 Heinze HJ, Mangun GR, Burchert W, et al. Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature. 1994; 372(6506): 543–6. (обратно) 205 Bateson M, Brilot B, Nettle D. Anxiety: an evolutionary approach. Can J Psychiatry. 2011; 56(12): 707–15. (обратно) 206 Lundström JN, Olsson MJ. Functional Neuronal Processing of Human Body Odors. Vitamins and hormones. 2010; 83: 1–23. doi: 10.1016/S0083–6729(10)83001–8. (обратно) 207 Morgan E. The Scars of Evolution. Oxford University Press on Demand; 100–1, 1994. (обратно) 208 Depersonalization: A New Look at a Neglected Syndrome By Mauricio Sierra, p. 154. (обратно) 209 Favazza, A. (2012). Nonsuicidal self-injury: How categorization guides treatment. Current Psychiatry, 11, 21–26. (обратно) 210 Prodigal Genius: The Life of Nikola Tesla By John J. O'Neil, 293. (обратно) 211 Wilson, Bee, The Telegraph, "Alfred Hitchcock's complicated relationship with food," (http://www.telegraph.co.uk/journalists/bee-wilson/9818987/Alfred-Hitchcocks-complicated-relationship-with-food.html), March 8, 2016. (обратно) 212 Salvador Dal', Or the Art of Spitting on Your Mother's Portrait By Carlos Rojas, p. 46. (обратно) 213 Rapee RM. Family factors in the development and management of anxiety disorders. Clin Child Fam Psychol Rev. 2012; 15 (1): 69–80. (обратно) 214 Kendler K, Karkowski L, Prescott C (1999). "Fears and phobias: reliability and heritability". Psychological Medicine 29 (3): 539–53. (обратно) 215 Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM – IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593–602. (обратно) 216 Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM – IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593–602. (обратно) 217 Брайсон Б. Краткая история почти всего на свете. – М.: АСТ, 2016. (обратно) 218 Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006; 63(4): 415. (обратно) 219 Yardley L, Britton J, Lear S, Bird J, Luxon LM. Relationship between balance system function and agoraphobic avoidance. Behav Res Ther. 1995; 33(4): 435–9. (обратно) 220 Jacob RG, Furman JM, Durrant JD, Turner SM. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry. 1996; 153(4): 503–12. (обратно) 221 http://neilhilborn.tumblr.com/post/56192842620/buttonpoetry-neil-hilborn-ocd-rustbelt (обратно) 222 Association, American Psychiatric (2013). Diagnostic and statistical manual of mental disorders: DSM-5. (5th ed.). Washington, D.C.: American Psychiatric Association. p. 237. (обратно) 223 Fitzgerald KD, Welsh RC, Stern ER, et al. Developmental alterations of frontal-striatal-thalamic connectivity in obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011; 50(9): 938–948.e3. doi: 10.1016/j.jaac.2011.06.011. (обратно) 224 Ahmari SE, Spellman T, Douglass NL, et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science. 2013; 340(6137): 1234–9. (обратно) 225 Miller JA, Research Update BioScience. Vol. 42, No. 4 (Apr., 1992), pp. 257–261. (обратно) 226 Einstein DA, Menzies RG. Role of magical thinking in obsessive-compulsive symptoms in an undergraduate sample. Depress Anxiety. 2004; 19(3): 174–9. (обратно) 227 Shin LM, Shin PS, Heckers S, et al. Hippocampal function in posttraumatic stress disorder. Hippocampus. 2004; 14(3): 292–300. (обратно) 228 Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley-davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 2012; 62(2): 628–37. (обратно) 229 Van der kolk B. Posttraumatic stress disorder and the nature of trauma. Dialogues Clin Neurosci. 2000; 2(1): 7–22. (обратно) 230 Hirschfeld RMA. The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care. Primary Care Companion to The Journal of Clinical Psychiatry. 2001; 3(6): 244–254. (обратно) 231 Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry. 1992; 49(9): 716–22. (обратно) 232 Allgulander C, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003; 8(8 Suppl 1): 53–61. (обратно) 233 Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord. 2000; 59(2): 119–26. (обратно) 234 Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013; 12(2): 137–48. (обратно) 235 Otte C. Cognitive behavioral therapy in anxiety disorders: current state of the evidence. Dialogues in Clinical Neuroscience. 2011; 13(4): 413–421. (обратно) 236 Clapp P, Bhave SV, Hoffman PL. How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health. 2008; 31(4): 310–39. (обратно) 237 Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. Journal of Psychiatry and Neuroscience. 2003; 28(4): 263–274. (обратно) 238 Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol Res. 2012; 34(4): 414–31. (обратно) 239 McGovern TF, White WL. Alcohol Problems in the United States, Twenty Years of Treatment Perspective. Haworth Press; 2002. 5–40. (обратно) 240 Somnath Banerjee (2012). ADHD in Children and Adolescents: A Good Practice Guidance, Current Directions in ADHD and Its Treatment, Dr. Jill M. Norvilitis (Ed.). (обратно) 241 Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008. (обратно) 242 Hodgkins P, Arnold LE, Shaw M, et al. A Systematic Review of Global Publication Trends Regarding Long-Term Outcomes of ADHD. Frontiers in Psychiatry. 2011; 2: 84. (обратно) 243 Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255. (обратно) 244 Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008. (обратно) 245 Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255. (обратно) 246 Strohl MP. Bradley's Benzedrine Studies on Children with Behavioral Disorders. The Yale Journal of Biology and Medicine. 2011; 84(1): 27–33. (обратно) 247 Myers RL. The 100 Most Important Chemical Compounds, A Reference Guide. ABC–CLIO; 2007: 178–80. (обратно) 248 Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. Financial ties between DSM – IV panel members and the pharmaceutical industry. Psychother Psychosom. 2006;75(3): 154–60. (обратно) 249 Americans With Disabilities Act of 1990, Pub. L. No. 101–336, 104 Stat. 328 (1990). (обратно) 250 Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245–25. (обратно) 251 Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010; 10: 67. (обратно) 252 Arria AM, Wish ED. Nonmedical Use of Prescription Stimulants Among Students. Pediatric annals. 2006; 35(8): 565–571. (обратно) 253 Garnier-Dykstra LM, Caldeira KM, Vincent KB, O'Grady KE, Arria AM. Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health: J of ACH. 2012; 60(3): 226–234. (обратно) 254 Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000; 10(4): 311–20. (обратно) 255 Faraone SV. Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T. 2009; 34(12): 678–94. (обратно) 256 Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014; 16(3). (обратно) 257 Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1): 51–90. (обратно) 258 Mccarthy H, Skokauskas N, Mulligan A, et al. Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood. JAMA Psychiatry. 2013; 70(12): 1329–37. (обратно) 259 Safer DJ, Krager JM. Treatment of Attention-Deficit Hyperactivity Disorder-Reply. JAMA. 1993; 269(18): 2369. (обратно) 260 Maraini D, Dacia Maraini Intervista Giorgio Antonucci. La Stampa, 26.7., 29 e 30.12.'78. (обратно) 261 Moffitt T, Melchior M. Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? The American Journal of Psychiatry. 2007; 146(6): 856–858. doi: 10.1176/appi.ajp.164.6.856. (обратно) 262 Shaw, P., Malek, M., Watson, B., Greenstein, D., de Rossi, P., & Sharp, W. (2013). Trajectories of Cerebral Cortical Development in Childhood and Adolescence and Adult Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 74, 599–606. (обратно) 263 Sripada CS, Kessler D, Angstadt M. Lag in maturation of the brain's intrinsic functional architecture in attention-deficit/hyperactivity disorder. Proc Natl Acad Sci USA. 2014; 111(39): 14259–64. (обратно) 264 Volkow ND, Wang G-J, Newcorn JH, et al. Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway. Molecular psychiatry. 2011;16(11): 1147–1154. doi: 10.1038/mp.2010.97. (обратно) 265 Голдберг Э. Управляющий мозг: Лобные доли, лидерство и цивилизация. – М.: Смысл, 2003. (обратно) 266 Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015. (обратно) 267 Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry. 2002; 41 (4): 378–85. (обратно) 268 Ibid. (обратно) 269 Hartmann T. Attention Deficit Disorder, A Different Perception. Underwood Books; 1997. (обратно) 270 Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015. (обратно) 271 Gilman L, Career Advice from the Corner Office: Famous People with ADHD, ADDitude, 2005 Dec-Jan. (обратно) 272 Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015. (обратно) 273 World Health Organization (2012). Pharmacological and nonpharmacological interventions for children with attention-deficit hyperactivity disorder (ADHD). Geneva: WHO. (обратно) 274 Philipsen A, Richter H, Peters J, et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007; 195(12): 1013–9. (обратно) 275 Weiss M, Murray C, Wasdell M, Greenfield B, Giles L, Hechtman L. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry. 2012; 12:30. doi: 10.1186/1471-244X-12–30. (обратно) 276 Morton WA, Stockton GG. Methylphenidate Abuse and Psychiatric Side Effects. Primary Care Companion to The Journal of Clinical Psychiatry. 2000; 2(5): 159–164. (обратно) 277 Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the Efficacy of Medications for ADHD Using Meta-analysis. Medscape General Medicine. 2006; 8(4): 4. (обратно) 278 Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005; 43(7): 831–42. (обратно) 279 Зиновьева А. Космический пришелец по имени Иван // Московский комсомолец. – 2013. – 5 июля (№ 26272). (обратно) 280 Schechter MD, Timmons GD. Objectively measured hyperactivity – II. Caffeine and amphetamine effects. J Clin Pharmacol. 1985; 25(4): 276–80. (обратно) 281 Arnold LE, Christopher J, Huestis R, Smeltzer DJ. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arch Gen Psychiatry. 1978; 35(4): 463–73. (обратно) 282 Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015. (обратно) 283 Wing L. The history of ideas on autism: Legends, myths and reality. Autism. 1997; 1: 13–23. (обратно) 284 Miles, M. "Martin Luther and Childhood Disability in 16th Century Germany: What Did He Write? What Did He Say?" Journal of Religion, Disability, and Health 5, no. 4: 5–36. (обратно) 285 Houston R, Frith U. Autism in History, The Case of Hugh Blair of Borgue. Wiley-Blackwell; 2000. (обратно) 286 Rapaport, David, (1951). Organization and pathology of thought: Selected sources., (pp. 399–437). New York, NY, US: Columbia University Press, xviii, 786 pp. (обратно) 287 Baron-Cohen S, Klin A. What's so special about Asperger Syndrome?. Brain Cogn. 2006; 61(1): 1–4. (обратно) 288 Wing L. Asperger's syndrome: a clinical account. Psychol Med. 1981; 11(1): 115–29. (обратно) 289 Silberman S. NeuroTribes, The Legacy of Autism and How to Think Smarter About People Who Think Differently. 2016. (обратно) 290 Feinstein A. A History of Autism, Conversations with the Pioneers. Wiley-Blackwell; 2010. (обратно) 291 Yu KK, Cheung C, Chua SE, Mcalonan GM. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J Psychiatry Neurosci. 2011; 36(6): 412–21. (обратно) 292 Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013; 12(2): 92–98. doi: 10.1002/wps.20050. (обратно) 293 Peek K., Inspiration for 'Rain Man,' Dies at 58, The New York Times, December 27, 2009, A30. (обратно) 294 Treffert DA. The savant syndrome and autistic disorder. CNS Spectr. 1999; 4(12): 57–60. (обратно) 295 Klin A. [Autism and Asperger syndrome: an overview]. Rev Bras Psiquiatr. 2006; 28 Suppl 1: S3–11. (обратно) 296 Klin A. [Autism and Asperger syndrome: an overview]. Rev Bras Psiquiatr. 2006; 28 Suppl 1: S3–11. (обратно) 297 Roy M, Dillo W, Emrich HM, Ohlmeier MD. Asperger's syndrome in adulthood. Dtsch Arztebl Int. 2009; 106(5): 59–64. (обратно) 298 Rogers SJ, Ozonoff S. Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry. 2005; 46(12): 1255–68. (обратно) 299 Allely CS. Pain Sensitivity and Observer Perception of Pain in Individuals with Autistic Spectrum Disorder. The Scientific World Journal. 2013; 2013: 916178. (обратно) 300 Green D, Baird G, Barnett AL, Henderson L, Huber J, Henderson SE. The severity and nature of motor impairment in Asperger's syndrome: a comparison with specific developmental disorder of motor function. J Child Psychol Psychiatry. 2002; 43(5): 655–68. (обратно) 301 Blakemore SJ, Tavassoli T, Calò S, et al. Tactile sensitivity in Asperger syndrome. Brain Cogn. 2006; 61(1): 5–13. (обратно) 302 Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 2011; 32(5): 1910–7. (обратно) 303 Miles JH, McCathren RB, Stichter J, et al. Autism Spectrum Disorders. 2003 Aug 27 [Updated 2010 Apr 13]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1442/ (обратно) 304 South M, Ozonoff S, Mcmahon WM. Repetitive behavior profiles in Asperger syndrome and high-functioning autism. J Autism Dev Disord. 2005; 35(2): 145–58. (обратно) 305 Boyd BA, McDonough SG, Bodfish JW. Evidence-Based Behavioral Interventions for Repetitive Behaviors in Autism. Journal of autism and developmental disorders. 2012; 42(6): 1236–1248. (обратно) 306 Newman SS, Ghaziuddin M. Violent crime in Asperger syndrome: the role of psychiatric comorbidity. J Autism Dev Disord. 2008; 38(10): 1848–52. (обратно) 307 Mouridsen SE, Rich B, Isager T, Nedergaard NJ. Pervasive developmental disorders and criminal behaviour: a case control study. Int J Offender Ther Comp Criminol. 2008; 52(2): 196–205. (обратно) 308 Mazefsky CA, Herrington J, Siegel M, et al. The Role of Emotion Regulation in Autism Spectrum Disorder RH: Emotion Regulation in ASD. Journal of the American Academy of Child and Adolescent Psychiatry. 2013; 52(7): 679–688. doi: 10.1016/j.jaac.2013.05.006. (обратно) 309 Ghaziuddin M, Tsai L, Ghaziuddin N. Brief report: violence in Asperger syndrome, a critique. J Autism Dev Disord. 1991; 21(3): 349–54. (обратно) 310 Castillo M., Asperger's not likely to make people violent, experts emphasize, CBS News, December 17, 2012. (обратно) 311 Baez S, Rattazzi A, Gonzalez-gadea ML, et al. Integrating intention and context: assessing social cognition in adults with Asperger syndrome. Front Hum Neurosci. 2012; 6: 302. (обратно) 312 Zalla T, Sav AM, Stopin A, Ahade S, Leboyer M. Faux pas detection and intentional action in Asperger Syndrome. A replication on a French sample. J Autism Dev Disord. 2009; 39(2): 373–82. (обратно) 313 Henry O'Connell and Michael Fitzgerald (2003). Did Alan Turing have Asperger's syndrome?. Irish Journal of Psychological Medicine, 20, pp. 28–31. (обратно) 314 Decety J, Moriguchi Y. The empathic brain and its dysfunction in psychiatric populations: implications for intervention across different clinical conditions. Biopsychosoc Med. 2007; 1: 22. (обратно) 315 Raftery B., How Dan Harmon Drives Himself Crazy Making Community, Wired, 09.2011. (обратно) 316 Grove R, Baillie A, Allison C, Baron-Cohen S, Hoekstra RA. The latent structure of cognitive and emotional empathy in individuals with autism, first-degree relatives and typical individuals. Molecular Autism. 2014; 5: 42. doi: 10.1186/2040-2392-5-42. (обратно) 317 Mazza M, Pino MC, Mariano M, et al. Affective and cognitive empathy in adolescents with autism spectrum disorder. Front Hum Neurosci. 2014; 8: 791. (обратно) 318 Mcintosh DN, Reichmann-decker A, Winkielman P, Wilbarger JL. When the social mirror breaks: deficits in automatic, but not voluntary, mimicry of emotional facial expressions in autism. Dev Sci. 2006; 9(3): 295–302. (обратно) 319 Markram H, Rinaldi T, Markram K. The Intense World Syndrome – an Alternative Hypothesis for Autism. Frontiers in Neuroscience. 2007; 1(1): 77–96. doi: 10.3389/neuro.01.1.1.006.2007. (обратно) 320 Hayashi M, Kato M, Igarashi K, Kashima H. Superior fluid intelligence in children with Asperger's disorder. Brain Cogn. 2008; 66(3): 306–10. (обратно) 321 Baron-Cohen S, Golan O, Ashwin E. Can emotion recognition be taught to children with autism spectrum conditions? Philosophical Transactions of the Royal Society B: Biological Sciences. 2009; 364(1535): 3567–3574. (обратно) 322 Segar M. Faire face, guide de survie à l'intention des personnes atteintes du syndrome d'Asperger. 1998. (обратно) 323 http://www.aspergers.ru/node/94 (обратно) 324 Willingham D., 'Wall Street' Actress Daryl Hannah Is An Autistic Woman, Forbes, 9.29.2013. (обратно) 325 Shattuck PT, Narendorf SC, Cooper B, Sterzing PR, Wagner M, Taylor JL. Postsecondary education and employment among youth with an autism spectrum disorder. Pediatrics. 2012; 129(6): 1042–9. (обратно) 326 James I. Singular scientists. Journal of the Royal Society of Medicine. 2003; 96(1): 36–39. (обратно) 327 Ruthsatz, J., & Urbach, J. B., Child prodigy: A novel cognitive profile places elevated general intelligence, exceptional working memory and attention to detail… Intelligence (2012). (обратно) 328 Baron-Cohen S, Bolton P, Wheelwright S, Scahill V, Short L, Mead G, Smith A. Does autism occur more often in families of physicists, engineers, and mathematicians? Autism. 1998; 2 (3): 296–301. (обратно) 329 Clarke T-K. et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Molecular Psychiatry. 2015. March 10. (обратно) 330 Frith U. Emanuel Miller lecture: confusions and controversies about Asperger syndrome. J Child Psychol Psychiatry. 2004; 45(4): 672–86. (обратно) 331 Grove R, Roth I, Hoekstra RA. The motivation for special interests in individuals with autism and controls: Development and validation of the special interest motivation scale. Autism Res. 2015. (обратно) 332 Prior M, Ozonoff S (2007). "Psychological factors in autism". In Volkmar FR. Autism and Pervasive Developmental Disorders (2nd ed.). Cambridge University Press. pp. 69–128. (обратно) 333 http://youtu.be/i_yJTCDU4uE (обратно) 334 Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007; 12(1): 2–22. (обратно) 335 Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006; 29(7): 349–58. (обратно) 336 Courchesne E, Mouton PR, Calhoun ME, et al. Neuron Number and Size in Prefrontal Cortex of Children With Autism. JAMA. 2011; 306(18): 2001–2010. (обратно) 337 Kanold PO. Subplate neurons: crucial regulators of cortical development and plasticity. Front Neuroanat. 2009; 3: 16. (обратно) 338 Hadjikhani N, Joseph RM, Snyder J, Tager-flusberg H. Anatomical differences in the mirror neuron system and social cognition network in autism. Cereb Cortex. 2006; 16(9): 1276–82. (обратно) 339 Cheng Y, Yang CY, Lin CP, Lee PL, Decety J. The perception of pain in others suppresses somatosensory oscillations: a magnetoencephalography study. Neuroimage. 2008; 40(4): 1833–40. (обратно) 340 Lamm C, Batson CD, Decety J. The neural substrate of human empathy: effects of perspective-taking and cognitive appraisal. J Cogn Neurosci. 2007; 19(1): 42–58. (обратно) 341 Botvinick M, Jha AP, Bylsma LM, Fabian SA, Solomon PE, Prkachin KM. Viewing facial expressions of pain engages cortical areas involved in the direct experience of pain. Neuroimage. 2005; 25(1): 312–9. (обратно) 342 Jabbi M, Swart M, Keysers C. Empathy for positive and negative emotions in the gustatory cortex. Neuroimage. 2007; 34(4): 1744–53. (обратно) 343 Hamilton AF. Goals, intentions and mental states: challenges for theories of autism. J Child Psychol Psychiatry. 2009; 50(8): 881–92. (обратно) 344 Dinstein I, Thomas C, Humphreys K, Minshew N, Behrmann M, Heeger DJ. Normal movement-selectivity in autism. Neuron. 2010; 66(3): 461–469. doi: 10.1016/j.neuron.2010.03.034. (обратно) 345 Ramachandran VS, Oberman LM. Broken mirrors: a theory of autism. Sci Am. 2006; 295(5): 62–9. (обратно) 346 Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a "theory of mind"?. Cognition. 1985; 21(1): 37–46. (обратно) 347 Ruffman T, Garnham W, Rideout P. Social understanding in autism: eye gaze as a measure of core insights. J Child Psychol Psychiatry. 2001; 42(8): 1083–94. (обратно) 348 RETRACTED: Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–41. (обратно) 349 Fraser M., Anti-MMR doctor is forced out, The Telegraph, 02 Dec 2001. (обратно) 350 Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. MP, Mol Pathol. 2002; 55(2): 84–90. (обратно) 351 Goldacre M., The MMR hoax, The Guardian, 30 August 2008. (обратно) 352 Health and Social Care Information Centre, NHS Immunisation Statistics England 2012–13, 26 September 2013. (обратно) 353 Deer B., MMR doctor Andrew Wakefield fixed data on autism, The Sunday Times, 8 February 2009. (обратно) 354 Horton R. The lessons of MMR. Lancet. 2004; 363 (9411): 747–9. (обратно) 355 Miriam Falco, Vaccine study's author held related patent, medical journal reports, CNN, January 12, 2011. (обратно) 356 RETRACTED: Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998; 351(9103): 637–41. (обратно) 357 Flaherty DK. The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 2011; 45(10): 1302–4. (обратно) 358 Health and Social Care Information Centre, NHS Immunisation Statistics England 2012–13, 26, September 2013. (обратно) 359 Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014; 32(29): 3623–9. (обратно) 360 Seida JK, Ospina MB, Karkhaneh M, Hartling L, Smith V, Clark B. Systematic reviews of psychosocial interventions for autism: an umbrella review. Dev Med Child Neurol. 2009; 51(2): 95–104. (обратно) 361 Eikeseth S. Outcome of comprehensive psycho-educational interventions for young children with autism. Res Dev Disabil. 2009; 30(1): 158–78. (обратно) 362 Buitelaar JK. Why have drug treatments been so disappointing?. Novartis Found Symp. 2003; 251: 235–44. (обратно) 363 Nicholas Lofthouse, Robert Hendren, Elizabeth Hurt, L. Eugene Arnold, and Eric Butter, "A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders," Autism Research and Treatment, vol. 2012, 2012. (обратно) 364 Tonya N. Davis et al., "Chelation Treatment for Autism Spectrum Disorders: A Systematic Review," Research in Autism Spectrum Disorders 7 (January 2013): 49–55. (обратно) 365 Tonya N. Davis et al., "Chelation Treatment for Autism Spectrum Disorders: A Systematic Review," Research in Autism Spectrum Disorders 7 (January 2013): 49–55. (обратно) 366 Myles, B. S., Huggins, A., Rome-Lake, M., Hagiwara, T., Barnhill, G. P., & Griswold, D. E. (2003). Written Language Profile of Children and Youth with Asperger Syndrome: From Research to Practice. Education and Training in Developmental Disabilities, 38(4), 362–369. (обратно) 367 Blume H., Autistics, freed from face-to-face encounters, are communicating in cyberspace. The New York Times, June 30, 1997. (обратно) 368 Saner E., 'It is not a disease, it is a way of life', The Guardian, 7 August 2007. (обратно) 369 https://www.autismspeaks.org/liub (обратно) 370 General Assembly resolution 62/139, World Autism Awareness Day, A/RES/62/139 (21 January 2008), available from undocs.org/A/RES/62/139. (обратно) 371 Morel BA. Traité des maladies mentales. [Treatise on mental diseases]. Paris, France: Masson; 1860. (обратно) 372 Berrios GE. Phthisical insanity by T. S. Clouston. Hist Psychiatry. 2005; 16(Pt 4 (no 64)): 473–9. (обратно) 373 Hecker E. Die Hebephrenie: ein Beitrag zur klinischen Psychiatrie. [Hebephrenia: a contribution to clinical psychiatry] Archiv für pathologische Anatomie und für klinische Medizin. 1871. (обратно) 374 Kahlbaum KL. Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen. [The Grouping of Psychiatric Diseases and the Classification of Mental Disturbances]. Danzig, Germany: Kafemann; 1863. (обратно) 375 Kraepelin E. Psychiatrie. 6 Auflage. Leipzig, Austria: Barth 1899. English translation by Metoui H, Ayed S: Psychiatry, A Textbook for Students and Physicians. (обратно) 376 Waters FA, Badcock JC, Dragovic´ M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms. Psychopathology. 2009; 42(1): 47–58. (обратно) 377 Wilkinson G. Political dissent and "sluggish" schizophrenia in the Soviet Union. British Medical Journal (Clinical research ed). 1986; 293(6548): 641–642. (обратно) 378 Bonnie RJ. Political abuse of psychiatry in the Soviet Union and in China: complexities and controversies. J Am Acad Psychiatry Law. 2002; 30(1): 136–44. (обратно) 379 World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. (обратно) 380 Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry. 1987; 151: 145–51. (обратно) 381 Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol Med. 1996; 26(4): 669–79. (обратно) 382 Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry. 1995; 52(5): 352–60. (обратно) 383 World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. (обратно) 384 Lindström, E et al., The ICD-10 and DSM – IV diagnostic criteria and the prevalence of schizophrenia, European Psychiatry, (1997). Volume 12, Issue 5, 217–223. (обратно) 385 Upthegrove R, Birchwood M, Ross K, Brunett K, Mccollum R, Jones L. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010; 122(3): 211–8. (обратно) 386 Sham PC, Maclean CJ, Kendler KS. A typological model of schizophrenia based on age at onset, sex and familial morbidity. Acta Psychiatr Scand. 1994; 89(2): 135–41. (обратно) 387 Brugha T, Singleton N, Meltzer H, et al. Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry. 2005; 162(4): 774–80. (обратно) 388 Ostling S, Skoog I. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Arch Gen Psychiatry. 2002; 59(1): 53–9. (обратно) 389 Лаувенг А. Завтра я всегда бывала львом. – М.: Бахрах-М, 2012. (обратно) 390 Trémeau F, Antonius D, Cacioppo JT, et al. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophr Res. 2009; 107(2–3): 223–31. (обратно) 391 De Clerambault, Psychoses a base d'automatisme (1925), La Psychiatrie, 1994: 511. (обратно) 392 Kiran C, Chaudhury S. Understanding delusions. Industrial Psychiatry Journal. 2009; 18(1): 3–18. (обратно) 393 О'Брайен Б. Необыкновенное путешествие в безумие и обратно: Операторы и вещи. – М.: Класс, 1996. (обратно) 394 Byrne P. Managing the acute psychotic episode. BMJ: British Medical Journal. 2007; 334(7595): 686–692. (обратно) 395 Van rensburg AB, Olorunju S. Diagnosis and treatment of schizophrenia in a general hospital based acute psychiatric ward. Afr J Psychiatry (Johannesbg). 2010; 13(3): 204–10. (обратно) 396 Surviving Schizophrenia: A Manual for Families, Patients, and Providers (5th Edition) by E. Fuller Torrey (Author), Publisher: Quill; 5th edition (April 1, 2006). (обратно) 397 Mitchison A., Kim Noble: The woman with 100 personalities, The Guardian, 30 September 2011. (обратно) 398 Nathan PE, Gorman JM. A Guide to Treatments that Work. Oxford University Press, USA; 2007: 463–5. (обратно) 399 Beidel DC, Frueh BC, Hersen M. Adult Psychopathology and Diagnosis. John Wiley & Sons; 2014. (обратно) 400 Korol S. Familial and social support as protective factors against the development of dissociative identity disorder. J Trauma Dissociation. 2008; 9(2): 249–67. (обратно) 401 Gillig PM. Dissociative identity disorder: a controversial diagnosis. Psychiatry (Edgmont). 2009; 6(3): 24–9. (обратно) 402 Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012; 25(3): 367–82. (обратно) 403 Burns A, Iliffe S. Dementia. BMJ. 2009; 338: b75. (обратно) 404 Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6(11): 994–1003. (обратно) 405 O'donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33. (обратно) 406 Torrey EF. Surviving Schizophrenia, 6th Edition, A Family Manual. Harper Perennial; 2013: 135. (обратно) 407 Van os J, Kapur S. Schizophrenia. Lancet. 2009; 374(9690): 635–45. (обратно) 408 Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry. 1999; 56(2): 162–8. (обратно) 409 Kendler KS, Mcguire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry. 1993; 50(7): 527–40. (обратно) 410 O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33. (обратно) 411 Torrey EF, Yolken RH. Psychiatric Genocide: Nazi Attempts to Eradicate Schizophrenia. Schizophrenia Bulletin. 2010; 36(1): 26–32. (обратно) 412 Crow TJ. Schizophrenia as the price that homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Res Brain Res Rev. 2000; 31(2–3): 118–29. (обратно) 413 Burns JK. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav Brain Sci. 2004; 27(6): 831–55. (обратно) 414 Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr Bull. 2009; 35(3): 549–62. (обратно) 415 Carlsson A., Carlsson ML. Dopaminergic stabilisers. Adv Schizophrenia and Clin Psychiatry. 2005; 1: 118–128. (обратно) 416 Da silva alves F, Figee M, Van amelsvoort T, Veltman D, De haan L. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull. 2008; 41(1): 121–32. (обратно) 417 Pogarell O, Koch W, Karch S, et al. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms. Pharmacopsychiatry, 2012; 45 Suppl 1: S36–41. (обратно) 418 Mechri A, Saoud M, Khiari G, D'amato T, Dalery J, Gaha L. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Encephale. 2001; 27(1): 53–9. (обратно) 419 Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophr Res. 2005; 73(2–3): 147–52. (обратно) 420 Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012; 38(5): 920–6. (обратно) 421 Richard A, Churan J, Whitford V, O'driscoll GA, Titone D, Pack CC. Perisaccadic perception of visual space in people with schizophrenia. J Neurosci. 2014; 34(14):4760–5. (обратно) 422 Bateson, G., Jackson, D. D., Haley, J. & Weakland, J. (1956), Towards a Theory of Schizophrenia. in Behavioral Science, Vol 1, 251–264. (обратно) 423 Large M, Smith G, Nielssen O. The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis. Schizophr Res. 2009; 112(1–3):123–9. (обратно) 424 Phelan, J. C., Link, B. G., Stueve, A., & Pescosolido, B. A. (2000). Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Illness and Is It to be Feared? Journal of Health and Social Behavior, 41(2), 188–207. (обратно) 425 Pronin, E., Perception and misperception of bias in human judgment, (2007) Trends in Cognitive Sciences, Volume 11, Issue 1, 37–43. (обратно) 426 Walsh E, Fahy T. Violence in society: Contribution of mental illness is low. BMJ: British Medical Journal. 2002; 325(7363): 507–508. (обратно) 427 Burton N. The Meaning of Madness. Oxford: Acheron Press, 2009; 2008. (обратно) 428 Kaufman SB, How Is Creativity Differentially Related to Schizophrenia and Autism? Scientific American, June 10, 2015 (обратно) 429 Marquis DM. In Search of Buddy Bolden, First Man of Jazz. LSU Press; 2005. (обратно) 430 Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry. 2005; 50(14): 892–900. (обратно) 431 Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001; 178: 506–17. (обратно) 432 Saks ER., Diary of a High-Functioning Person with Schizophrenia, Scientific American, December 29, 2009. (обратно) 433 Wiersma D, Wanderling J, Dragomirecka E, et al. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med. 2000; 30 (5): 1155–67. (обратно) 434 Ruhrmann S, Schultze-lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010; 67(3): 241–51. (обратно) 435 Doroshow DB. Performing a cure for schizophrenia: insulin coma therapy on the wards. J Hist Med Allied Sci. 2007;62 (2):213–43. (обратно) 436 Raz M. The painless brain: lobotomy, psychiatry, and the treatment of chronic pain and terminal illness. Perspect Biol Med. 2009; 52(4): 555–65. (обратно) 437 Epstein NN. Artificial Fever as a Therapeutic Procedure. Cal West Med. 1936; 44(5): 357–8. (обратно) 438 "The Nobel Prize in Physiology or Medicine 1927". Nobelprize.org. Nobel Media AB2014. Web. 14 Mar 2016. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1927/ (обратно) 439 Hamon, Paraire, Velluz. [Effect of R. P. 4560 on maniacal agitation]. Ann Med Psychol (Paris). 1952; 110: 331–5. (обратно) 440 Ban TA. Fifty years chlorpromazine: a historical perspective. Neuropsychiatric Disease and Treatment. 2007; 3(4): 495–500. (обратно) 441 Ban TA. Pharmacotherapy of mental illness – a historical analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(4): 709–27. (обратно) 442 Carlsson A, Carlsson ML. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues in Clinical Neuroscience. 2006; 8(1):137–142. (обратно) 443 Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010; 81(5): 617–22. (обратно) 444 Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry. 2007; 18(1): 39–60. (обратно) 445 Brisch R, Saniotis A, Wolf R, et al. The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue. Frontiers in Psychiatry. 2014; 5:47. doi: 10.3389/fpsyt.2014.00047. (обратно) 446 Xiberas X, Martinot JL, Mallet L, et al. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry. 2001; 179: 503–8. (обратно) 447 Хаэр Р. Лишенные совести: Пугающий мир психопатов. – М.: Вильямс, 2014. (обратно) 448 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992. (обратно) 449 American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing. (обратно) 450 Ющенко А. И. Основы учений о преступнике, душевнобольном и психологии нормального человека. Введение в курс судебной психопатологии. – СПб.: Издание К. Л. Риккера, 1913. (обратно) 451 Каннабих Ю. В. История психиатрии. – Л.: Государственное медицинское издательство, 1928. (обратно) 452 Буянин Д. Диспут о Канте закончился стрельбой в Ростове // РИА «Новости». 2013. 16 сентября. (обратно) 453 Bürgy M. The Concept of Psychosis: Historical and Phenomenological Aspects. Schizophrenia Bulletin. 2008; 34(6):1200–1210. (обратно) 454 Ferrero J. Lombroso's Criminal Man. – N.Y., 1919. – P. XIV. (обратно) 455 Goring C. The English Convict. – L., 1913. – P. 173. (обратно) 456 Cleckley, Hervey (1982). The Mask of Sanity. Revised Edition. Mosby Medical Library. (обратно) 457 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC American Psychiatric Association; 1980. (обратно) 458 Hare, R. D. (1980). A research scale for the assessment of psychopathy in criminal populations. Personality and Individual Differences, 1, 111–117. (обратно) 459 Хаэр Р. Лишенные совести: Пугающий мир психопатов. – М.: Вильямс, 2014. (обратно) 460 Moran P. The epidemiology of antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol. 1999; 34(5): 231–42. (обратно) 461 Хаэр Р. Лишенные совести: Пугающий мир психопатов. – М.: Вильямс, 2014. (обратно) 462 Antisocial Personality Disorder: Treatment, Management and Prevention. NICE Clinical Guidelines, No. 77. National Collaborating Centre for Mental Health (UK).Leicester (UK): British Psychological Society; 2010. (обратно) 463 Lilienfeld SO. Doctoral Dissertation. University of Minnesota; Minneapolis: 1990. Development and preliminary validation of a slf-report of psychopathic personality. (обратно) 464 Даттон К. Мудрость психопатов. – СПб.: Питер, 2014. (обратно) 465 McWilliams N. Psychoanalytic Diagnosis, Understanding Personality Structure in the Clinical Process. Guilford Press; 1994. (обратно) 466 Kent A. Kiehl, Peter F. Liddle, Andra M. Smith, Adrianna Mendrek, Bruce B. Forster and Robert D. Hare. Neural pathways involved in the processing of concrete and abstract words. Psychophysiology, 36 (1999). (обратно) 467 Thomas ST, Sociopaths Confirm: They're Great in Bed (But They Might Treat You Like a Houseplant), Vice, July 19, 2015. (обратно) 468 http://www.sociopathworld.com/ (обратно) 469 Dutton DL. The cold reading technique. Experientia. 1988; 44(4): 326–32. (обратно) 470 Wheeler S, Book A, Costello K. Psychopathic Traits and Perceptions of Victim Vulnerability, Criminal Justice and Behavior Volume:36 Issue:6, June 2009: 635–48. (обратно) 471 Cleckley HM. The Mask of Sanity. Textbook Pub; 2003. (обратно) 472 Eysenck EJ, Personality and the Biosocial Model of Anti-Social and Criminal Behaviour, Biosocial Bases of Violence, Springer US, 1997: 21–37. (обратно) 473 Quay, Herbert C. 1965. Psychopathic personality as pathological stimulation seeking. American Journal of Psychiatry, 122, 180–183. (обратно) 474 Raine A, Fung AL, Portnoy J, Choy O, Spring VL. Low heart rate as a risk factor for child and adolescent proactive aggressive and impulsive psychopathic behavior. Aggress Behav. 2014; 40(4): 290–9. (обратно) 475 Raine A, Venables PH, Mednick SA. Low resting heart rate at age 3 years predisposes to aggression at age 11 years: evidence from the Mauritius Child Health Project. J Am Acad Child Adolesc Psychiatry. 1997; 36(10): 1457–64. (обратно) 476 Ortiz J, Raine A. Heart rate level and antisocial behavior in children and adolescents: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2004; 43(2): 154–62. (обратно) 477 From Craig, M., Catani, M., Deeley, Q., Latham, R., Daly, E., Kanaan, R., Picchioni, M., McGuire, P., Fahy, T., & Murphy, D. (2009). Altered connections on the road to psychopathy Molecular Psychiatry, 14 (10), 946–953 DOI: 10.1038/mp.2009.40. (обратно) 478 Koenigs M, Kruepke M, Newman JP. Economic decision-making in psychopathy: a comparison with ventromedial prefrontal lesion patients. Neuropsychologia. 2010; 48(7): 2198–204. (обратно) 479 McWilliams N. Psychoanalytic Diagnosis, Understanding Personality Structure in the Clinical Process. Guilford Press; 1994. (обратно) 480 Rothemund Y, Ziegler S, Hermann C, et al. Fear conditioning in psychopaths: event-related potentials and peripheral measures. Biol Psychol. 2012; 90(1): 50–9. (обратно) 481 Birbaumer N, Veit R, Lotze M, et al. Deficient fear conditioning in psychopathy: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2005; 62(7): 799–805. (обратно) 482 Hare RD. Detection threshold for electric shock in psychopaths. J Abnorm Psychol. 1968; 73(3): 268–72. (обратно) 483 Blair, R. J. R. (2010). Psychopathy, frustration, and the role of reactive aggression: The role of the ventromedial prefrontal cortex. British Journal of Psychology, 101, 383–399. (обратно) 484 Buckholtz JW, Treadway MT, Cowan RL, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci. 2010; 13(4): 419–21. (обратно) 485 Konnikova M, Stop Calling Sherlock a Sociopath! Thanks, a Psychologist, Criminal Element, Aug 8 2012, Available at: http://www.criminalelement.com/blogs/2012/08/stop-calling-sherlock-a-sociopath-psychologist-maria-konnikova. Accessed March 16, 2016. (обратно) 486 Craig, M., Catani, M., Deeley, Q., Latham, R., Daly, E., Kanaan, R., Picchioni, M., McGuire, P., Fahy, T., & Murphy, D. (2009). Altered connections on the road to psychopathy Molecular Psychiatry, 14 (10). (обратно) 487 Kevin M. Beavera, Matt DeLisib, Michael G. Vaughnc, J. C. Barnesa. Monoamine oxidase A genotype is associated with gang membership and weapon use. (обратно) 488 Caspi A et al, Role of Genotype in the Cycle of Violence in Maltreated Children, Science, 2002 (5582/297): 851–4 (обратно) 489 Khalifa N, Duggan C, Stoffers J, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010; (8): CD007667. (обратно) 490 Harris Grant T, et al. Psychopathy and Violent Recidivism. Law & Hum Behav. 1991; 15: 625. (обратно) 491 http://www.worldsciencefestival.com/2011/09/moth_confessions_of_a_pro_social_psychopath/ (обратно) 492 Morton RJ, Serial Murder: Multi-Disciplinary Perspectives for Investigators, National Ctr for the Analysis of Violent Crime (NCAVC), 2008. (обратно) 493 Hasler G, Hopwood CJ, Jacob GA, Brändle LS, Schulte-vels T. Patient-reported outcomes in borderline personality disorder. Dialogues Clin Neurosci. 2014; 16(2): 255–66. (обратно) 494 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author: 663–6. (обратно) 495 Cohen P. Child development and personality disorder. Psychiatr Clin North Am. 2008; 31(3): 477–93, vii. (обратно) 496 Zanarini MC, Frankenburg FR, Reich DB, et al. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3): 264–73. (обратно) 497 Zanarini MC, Frankenburg FR. Pathways to the development of borderline personality disorder. J Pers Disord. 1997; 11(1): 93–104. (обратно) 498 Goldman SJ, D'angelo EJ, Demaso DR. Psychopathology in the families of children and adolescents with borderline personality disorder. Am J Psychiatry. 1993; 150(12): 1832–5. (обратно) 499 South SC, Turkheimer E, Oltmanns TF. Personality disorder symptoms and marital functioning. J Consult Clin Psychol. 2008; 76(5): 769–80. (обратно) 500 Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006; 188: 423–31. (обратно) 501 Samuels J, Eaton WW, Bienvenu OJ, Brown CH, Costa PT, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002; 180: 536–42. (обратно) 502 Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001; 58(6): 590–6. (обратно) 503 Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM – IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008; 69(4): 533–45. (обратно) 504 Skodol AE, Gunderson JG, Mcglashan TH, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002; 159(2): 276–83. (обратно) 505 Oumaya M, Friedman S, Pham A, Abou abdallah T, Guelfi JD, Rouillon F. [Borderline personality disorder, self-mutilation and suicide: literature review]. Encephale. 2008; 34(5): 452–8. (обратно) 506 Bui E, Rodgers R, Chabrol H, Birmes P, Schmitt L. Is Anakin Skywalker suffering from borderline personality disorder? Psychiatry Res. 2011; 185(1–2): 299. (обратно) 507 Kreger R, Putting Darth Vader On The Couch, Psychology Today, Jun 2010. (обратно) 508 Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000; 41(6): 416–25. (обратно) 509 Reichborn-kjennerud T, Czajkowski N, Neale MC, et al. Genetic and environmental influences on dimensional representations of DSM – IV cluster C personality disorders: a population-based multivariate twin study. Psychol Med. 2007; 37(5): 645–53. (обратно) 510 Gratz AC. The Borderline Personality Disorder: Everything You Need to Know about Living with Bpd (Large Print 16pt). ReadHowYouWant.com; 2010. (обратно) 511 Miller PM, Lisak D, Associations Between Childhood Abuse and Personality Disorder Symptoms in College Males J Interpers Violence June 1999, 14: 642–656. (обратно) 512 Cohen P. Child development and personality disorder. Psychiatr Clin North Am. 2008; 31(3): 477–93, vii. (обратно) 513 Zanarini MC, Frankenburg FR, Reich DB, et al. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3): 264–73. (обратно) 514 Waters E, Merrick S, Treboux D, Crowell J, Albersheim L. Attachment security in infancy and early adulthood: a twenty-year longitudinal study. Child Dev. 2000; 71(3): 684–9. (обратно) 515 Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996; 274(5292): 1527–31. (обратно) 516 Rinne T, Westenberg HG, Den boer JA, Van den brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol Psychiatry. 2000; 47(6): 548–56. (обратно) 517 Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001; 50(4): 292–8. (обратно) 518 Gunderson JG, Sabo AN. The phenomenological and conceptual interface between borderline personality disorder and PTSD. Am J Psychiatry. 1993; 150(1): 19–27. (обратно) 519 Twenge JM, Gentile B, Dewall CN, Ma D, Lacefield K, Schurtz DR. Birth cohort increases in psychopathology among young Americans, 1938–2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010; 30(2): 145–54. (обратно) 520 Tebartz van elst L, Hesslinger B, Thiel T, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003; 54(2): 163–71. (обратно) 521 Rausch J, Gäbel A, Nagy K, Kleindienst N, Herpertz SC, Bertsch K. Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter. Psychoneuroendocrinology. 2015; 55: 116–27. (обратно) 522 Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM – IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007; 62(6): 553–64. (обратно) 523 Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003; 160(2): 274–83. (обратно) 524 Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007; 27(8): 959–85. (обратно) 525 Kane JM, Jeste DV, Barnes TR: Tardive dyskinesia: A task force report of the American Psychiatric Association. Washington, D.C: American Psychiatric Association; 1992. Ref Type: Report. (обратно) 526 Ebert A, Kolb M, Heller J, Edel MA, Roser P, Brüne M. Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma. Soc Neurosci. 2013; 8(4): 305–13. (обратно) 527 Bertsch K, Gamer M, Schmidt B, et al. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. Am J Psychiatry. 2013; 170(10): 1169–77. (обратно) 528 Amad A, Thomas P, Perez-rodriguez MM. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions. Curr Pharm Des. 2015; 21(23): 3311–6. (обратно) 529 Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry. 2001; 158(1): 36–42. (обратно) 530 Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009; 166(12): 1355–64. (обратно) 531 Закон Российской Федерации от 2 июля 1992 г. № 3185-I (ред. от 21.11.2011 г.) «О психиатрической помощи и гарантиях прав граждан при ее оказании», ст. 27. (обратно)(обратно) Оглавление · Предисловие научного редактора · Введение Зачем мы написали эту книгу · Глава 1 В безумии есть свой метод, или Откуда берутся расстройства · Где заканчивается психическая норма · Чем измерять? · Значит, все относительно? · Мысль материальна · Наука без понимания фундаментальных причин? Это как? · И как же мы это сделаем без понимания причин? · Над кукушкиным гнездом: неудобные вопросы психиатрии · Темное прошлое · Психофармакологическое лобби · Права человека и насильственная госпитализация · Рост числа диагнозов и стигматизация · Плохой человек – больной человек · Как разложить психику по полочкам · Трехслойная конструкция · Откуда что берется · Бытие и сознание · На пороге расстройства · Амок или меланхолия: может ли культура формировать психические расстройства · Резюме · Глава 2 Поцелуй дементора: что такое депрессия · Потерянные письма: что происходит с мозгом в депрессии · «Да разве это депрессия?» · Реальные проблемы · Великий уравнитель · Антидепрессант – таблетка счастья? · История лечения · Психотерапия · Резюме · Глава 3 Качели настроения: что такое биполярное расстройство · Немного истории · «Но у всех же бывают перепады настроения…» · Ослепительный подъем… · …Изнурительный спад · …Или все сразу · Быстрые качели, или Циклотимия · Гены и нейрохимия: почему возникает биполярное расстройство · Болезнь Байрона и Хемингуэя · Мания и маньяки: опасен ли человек с БАР для окружающих · Что нужно знать о лечении БАР · Резюме · Глава 4 Как страшно жить: что такое тревожные расстройства · Почему мы боимся? · Беспочвенные тревоги · От истерии до подавленного либидо · Врожденные инстинкты и условные рефлексы · Нейрофизиология и генетика · Боюсь не знаю чего: что такое генерализованное тревожное расстройство · Внезапная атака: что такое паническое расстройство · Источник опасности: что такое фобическое тревожное расстройство · Под защитой ритуала: что такое обсессивно-компульсивное расстройство · Синдром Рэмбо: что такое посттравматическое стрессовое расстройство · Лечение · Резюме · Глава 5 Потеря фокуса: что такое синдром дефицита внимания · Начинается в детстве… · …И продолжается во взрослом возрасте · Три ипостаси СДВГ · С чего все началось: Беспокойный Фил и отчаянные домохозяйки · Так, может, это вообще не болезнь? · Как это устроено: фонарик в голове и ген исследователя · Охотники и земледельцы · Как c дефицитом внимания стать миллиардером… или написать «Тома Сойера» · Как пережить СДВГ: таблетки для космонавтов, кофеин и балет · Резюме · Глава 6 Весь в себе: что такое синдром Аспергера[3] · Проделки фей и «Человек дождя» · Жутко громко и запредельно близко · Помогите мне отреагировать · Гены Кремниевой долины · Как это устроено: зеркальные нейроны и наследственность · Страшилки о прививках · Можно ли вылечить синдром Аспергера? · Аспи и нейротипики · Резюме · Глава 7 Расщепление души: что такое шизофрения · Ступор и дурашливость · «Вялотекущая шизофрения» и карательная медицина · Пикассо в голове · Путаница в симптомах · Нежелательное наследство? · В начале было слово · Неравенство рецепторов · Это все не я · Дурное воспитание · Параноик с топором: насколько опасны шизофреники? · Весь этот джаз · Диагноз, но не приговор · От малярии до нейролептиков · Резюме · Глава 8 Игра в имитацию: что такое антисоциальное расстройство · Психоз или психопатия? · «Нравственное помешательство» · Психопат-тест · Бытие и ничто · Эмоциональный сканер · Безумство храбрых · Диагноз Шерлока · Природа или воспитание? · Это лечится? · Слово психопатам · Хищники и мы · Резюме · Глава 9 Без полутонов: что такое пограничное расстройство · Энакин Скайуокер и «Клуб 27» · Гены или воспитание? · Нейробиология · Как это лечить? · Резюме · Глава 10 Кажется, со мной что-то не так. Что делать? · Что случится, если я попаду на прием к психиатру? · Что такое амбулаторная помощь? · Как сняться с учета, если мне полегчало? · В каких случаях имеет смысл добровольно ложиться в стационар? · Что такое дневной стационар? · Могут ли меня насильно отправить в стационар прямо из кабинета психиатра? · Как психиатрический диагноз может повлиять на карьеру? · Как диагноз влияет на признание вменяемости и дееспособности? · Что выбрать: ПНД или частную клинику? · Какие законы регулируют сферу психиатрии в России? · Итак, стоит ли оно того? · Благодарности · Список фильмов и книг для тех, кому интересна психиатрия[6] · Депрессия · Биполярное расстройство · Тревожные расстройства · Синдром Аспергера · СДВГ · Шизофрения · Антисоциальное расстройство · Пограничное расстройство |
Последнее изменение этой страницы: 2019-06-09; Просмотров: 223; Нарушение авторского права страницы